+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis



Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis



Journal of Magnetic Resonance Imaging 3(5): 786-793



The hepatocyte-specific paramagnetic magnetic resonance (MR) contrast agents manganese-DPDP [N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'bis-(phosphate)] and gadobenate dimeglumine were used for diagnosing chemically induced hepatitis in rats. Ex vivo liver tissue relaxation times and in vivo MR image signal-to-noise ratios were compared before and after contrast agent administration. Ex vivo relaxometry and in vivo MR imaging showed that Mn-DPDP enhanced normal and diseased livers to the same degree at all time points from 5 to 120 minutes. Gadobenate dimeglumine showed reduced T1 and T2 enhancements in hepatitis relative to those of normal liver, in the early phase (5-30 minutes). However, these effects are offsetting, and as a result, MR imaging failed to allow distinction of diseased from normal livers. This surprising result observed in vivo was in fact predicted by applying the Bloch equation to our ex vivo data. Our results show that detection and quantitation of hepatitis with MR imaging enhanced with paramagnetic cell-specific contrast agents will be more difficult than anticipated.

(PDF emailed within 0-6 h: $19.90)

Accession: 046010308

Download citation: RISBibTeXText

PMID: 8400566

DOI: 10.1002/jmri.1880030515


Related references

Evaluation of the hepatocyte-specific contrast agent gadobenate dimeglumine for MR imaging of acute hepatitis in a rat model. Journal of Magnetic Resonance Imaging 7(1): 147-152, 1997

Evaluation of hepatic contrast enhancement with a hepatocyte-specific magnetic resonance imaging contrast agent (gadoxetic acid) in healthy dogs. American Journal of Veterinary Research 76(3): 224-230, 2015

Contrast enhancement in magnetic resonance imaging using intravenous paramagnetic contrast media: A review. Veterinary Radiology & Ultrasound 41(1): 4-7, 2000

Nuclear magnetic resonance tomography: better images with contrast media. Contrast caused by paramagnetic properties--also imaging of the abdomen. Fortschritte der Medizin 106(27): 74-75, 1988

Recommendations of the European Society of Urogenital Radiology on the use of contrast media and the opportunity to use paramagnetic contrast in patients allergic to iodinated contrast media treated with endourology. Actas Urologicas Espanolas 26(10): 820-820, 2003

Paramagnetic contrast media for magnetic resonance imaging of the mediastinum and lungs. Journal of Thoracic Imaging 1(1): 74-78, 1985

Hepatocyte-specific contrast media: not so simple. Pediatric Radiology 48(9): 1245-1255, 2018

Paramagnetic contrast media for magnetic resonance imaging of the central nervous system. Brant Zawadzki, M. Norman (ed.). Magnetic Resonance Imaging Of The Central Nervous System. Xii 404p. Raven Press: New York, New York, Usa. Illus. 97-106, 1987

Hepatocyte-specific contrast media for CT. An experimental investigation. Acta Radiologica. Supplementum 411: 1-27, 1997

Preclinical evaluation of severely defective manganese-based nanocrystal as a liver-specific contrast media for MR imaging: comparison with Gd-EOB-DTPA and Mn-DPDP. Nanotechnology, 2018

Liver-specific contrast media for magnetic resonance imaging and computed tomography scanning: importance of contrast media for tumor detection in an experimental liver tumor model. Academic Radiology 3 Suppl 2: S420-S422, 1996

Hepatocyte-specific magnetic resonance imaging contrast agents. Hepatology 53(2): 678-682, 2011

Detection of macrophage infiltration in vulnerable atherosclerotic plaque using magnetic resonance imaging contrast media Super paramagnetic iron oxide. American Journal of Cardiology 86(Suppl 8A): 87i, October 16, 2000

Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media. La Radiologia Medica 100(4): 245-250, 2001

Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178(1): 73-78, 1991